A Study of Ibandronate (Bondronat) in Participants With Malignant Bone Disease

NCT02561039 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

97

Enrollment

INDUSTRY

Sponsor class

Conditions

Pain; Bone Neoplasms; Neoplasm Metastasis

Interventions

DRUG: Ibandronate

Sponsor

Hoffmann-La Roche